Evidence map›Paper›PMID 33766890›Full record

ArticleCancer research2021

Nuclear Receptor Coactivator NCOA3 Regulates UV Radiation-Induced DNA Damage and Melanoma Susceptibility.

David de Semir, Vladimir Bezrookove, Mehdi Nosrati, Altaf A Dar, James R Miller, Stanley P Leong, Kevin B Kim, Wilson Liao, Liliana Soroceanu, Sean McAllister and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Cancer research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Clinicopathologic and Molecular Genetic Features of Spindle Cell Rhabdomyosarcoma Harboring ZFP64::NCOA2/3 Fusions: A Series of 14 Cases.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2025
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

David de SemirCenter for Melanoma Research and Treatment, California Pacific Medical Center Research Institute, San Francisco, California.
Vladimir BezrookoveCenter for Melanoma Research and Treatment, California Pacific Medical Center Research Institute, San Francisco, California.
Mehdi NosratiCenter for Melanoma Research and Treatment, California Pacific Medical Center Research Institute, San Francisco, California.ORCID 0000-0002-0114-5864
Altaf A DarCenter for Melanoma Research and Treatment, California Pacific Medical Center Research Institute, San Francisco, California.
James R MillerCenter for Melanoma Research and Treatment, California Pacific Medical Center Research Institute, San Francisco, California.
Stanley P LeongCenter for Melanoma Research and Treatment, California Pacific Medical Center Research Institute, San Francisco, California.
Kevin B KimCenter for Melanoma Research and Treatment, California Pacific Medical Center Research Institute, San Francisco, California.
Wilson LiaoDepartment of Dermatology, University of California San Francisco, San Francisco, California.
Liliana SoroceanuCalifornia Pacific Medical Center Research Institute, San Francisco, California.
Sean McAllisterCalifornia Pacific Medical Center Research Institute, San Francisco, California.
Robert J DebsCalifornia Pacific Medical Center Research Institute, San Francisco, California.
Dirk SchadendorfDepartment of Dermatology, University Duisburg-Essen, Essen, Germany.ORCID 0000-0003-3524-7858
Sancy A LeachmanDepartment of Dermatology and Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.
James E CleaverDepartment of Dermatology, University of California San Francisco, San Francisco, California.
Mohammed Kashani-SabetCenter for Melanoma Research and Treatment, California Pacific Medical Center Research Institute, San Francisco, California. kashani@cpmcri.org.ORCID 0000-0001-5265-0011
California Pacific Medical Center · USUniversity of California, San Francisco · USGerman Cancer Research Center · DEOregon Health & Science University · US

Funding

Validation of Genomic Targets in MelanomaR01CA114337 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KASHANI-SABET, MOHAMMED · 2005 to 2015
$3.2M
Targeting BPTF in the Therapy of BRAF-mutant MelanomaR01CA215755 · NCI · CALIFORNIA PACIFIC MED CTR RES INSTITUTE · PI KASHANI-SABET, MOHAMMED · 2017 to 2021
$3.1M
PHIP as a Biomarker of Triple-Negative MelanomaR01CA175768 · NCI · CALIFORNIA PACIFIC MED CTR RES INSTITUTE · PI KASHANI-SABET, MOHAMMED · 2014 to 2017
$1.7M
Molecular Classification of Primary Cutaneous MelanomaR01CA122947 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KASHANI-SABET, MOHAMMED · 2007 to 2011
$1.5M
NCI NIH HHS R01 CA114337NCI NIH HHS R01 CA122947NCI NIH HHS R01 CA175768NCI NIH HHS R01 CA215755
6 · The paper itself

Abstract

Melanoma occurs as a consequence of inherited susceptibility to the disease and exposure to UV radiation (UVR) and is characterized by uncontrolled cellular proliferation and a high mutational load. The precise mechanisms by which UVR contributes to the development of melanoma remain poorly understood. Here we show that activation of nuclear receptor coactivator 3 (NCOA3) promotes melanomagenesis through regulation of UVR sensitivity, cell-cycle progression, and circumvention of the DNA damage response (DDR). Downregulation of NCOA3 expression, either by genetic silencing or small-molecule inhibition, significantly suppressed melanoma proliferation in melanoma cell lines and patient-derived xenografts. NCOA3 silencing suppressed expression of xeroderma pigmentosum C and increased melanoma cell sensitivity to UVR. Suppression of NCOA3 expression led to activation of DDR effectors and reduced expression of cyclin B1, resulting in G

Indexed as

DNA DamageAnimalsApoptosisBiomarkers, TumorCell ProliferationFemaleGene Expression Regulation, NeoplasticHumansMelanomaMiceMice, NudeMutationNuclear Receptor Coactivator 3Radiation InjuriesTumor Cells, CulturedUltraviolet RaysBiomarkers, TumorNCOA3 protein, humanNuclear Receptor Coactivator 3

Identifiers

PMID33766890
PMCPMC8178194
OpenAlexW3136323846

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.